Free Trial
NYSE:GRDN

Guardian Pharmacy Services (GRDN) Stock Price, News & Analysis

Guardian Pharmacy Services logo
$21.57 +0.56 (+2.67%)
As of 03:58 PM Eastern

About Guardian Pharmacy Services Stock (NYSE:GRDN)

Key Stats

Today's Range
$20.67
$21.67
50-Day Range
$18.37
$23.03
52-Week Range
$14.16
$25.74
Volume
56,224 shs
Average Volume
157,890 shs
Market Capitalization
$1.37 billion
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
$22.00
Consensus Rating
Buy

Company Overview

Guardian Pharmacy Services, Inc., a pharmacy service company, provides a suite of technology-enabled services designed to help residents of long-term health care facilities (LTCFs) in the United States. Its individualized clinical, drug dispensing, and administration capabilities are used to serve the needs of residents in lower acuity LTCFs, such as assisted living facilities and behavioral health facilities and group homes. The company's Guardian Compass includes dashboards created using data from its data warehouse to help its local pharmacies plan, track, and optimize their business operations; and GuardianShield Programs for LTCFs. The company was founded in 2003 and is based in Atlanta, Georgia.

Remove Ads
Receive GRDN Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Guardian Pharmacy Services and its competitors with MarketBeat's FREE daily newsletter.

GRDN Stock News Headlines

Trump to unlock 15-figure fortune for America (May 3rd) ?
We were shown this map by former Presidential Advisor, Jim Rickards, one of the most politically connected men in America. Rickards has spent his fifty-year career in the innermost circles of the U.S. government and banking. And he believes Trump could soon release this frozen asset to the public.
Guardian Pharmacy reports Q4 EPS 19c, consensus 22c
Guardian Pharmacy sees FY25 revenue $1.33B-$1.35B, consensus $1.34B
Q4 2024 Guardian Pharmacy Services Inc Earnings Call
See More Headlines

GRDN Stock Analysis - Frequently Asked Questions

Guardian Pharmacy Services' stock was trading at $20.26 at the beginning of 2025. Since then, GRDN shares have increased by 6.5% and is now trading at $21.57.
View the best growth stocks for 2025 here
.

Guardian Pharmacy Services, Inc. (NYSE:GRDN) announced its earnings results on Tuesday, November, 12th. The company reported ($2.00) EPS for the quarter, missing the consensus estimate of $0.19 by $2.19. The business had revenue of $314.39 million for the quarter, compared to analysts' expectations of $303.21 million.

Guardian Pharmacy Services (GRDN) raised $102 million in an initial public offering (IPO) on Thursday, September 26th 2024. The company issued 6,800,000 shares at a price of $14.00-$16.00 per share. Raymond James, Stifel and Truist Securities served as the underwriters for the IPO.

Guardian Pharmacy Services' lock-up period expired on Tuesday, March 25th. Guardian Pharmacy Services had issued 8,000,000 shares in its public offering on September 26th. The total size of the offering was $112,000,000 based on an initial share price of $14.00. Since the end of the company's lock-up period, restrictions preventing major shareholders and company insiders from selling shares in the company have been lifted.

Shares of GRDN stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.

Based on aggregate information from My MarketBeat watchlists, some other companies that Guardian Pharmacy Services investors own include UnitedHealth Group (UNH) and Meta Platforms (META).

Company Calendar

Last Earnings
11/12/2024
Today
4/02/2025
Fiscal Year End
12/31/2025

Industry, Sector and Symbol

Stock Exchange
NYSE
Sector
Medical
Industry
Drug stores & proprietary stores
Sub-Industry
Retail
Current Symbol
NYSE:GRDN
Previous Symbol
NYSE:GRDN
Fax
N/A
Employees
3,200
Year Founded
N/A

Price Target and Rating

Average Stock Price Target
$22.00
High Stock Price Target
$24.00
Low Stock Price Target
$21.00
Potential Upside/Downside
+4.1%
Consensus Rating
Buy
Rating Score (0-4)
3.00
Research Coverage
3 Analysts

Profitability

Trailing P/E Ratio
N/A
Forward P/E Ratio
N/A
P/E Growth
N/A
Pretax Margin
N/A

Debt

Sales & Book Value

Annual Sales
$1.23 billion
Price / Cash Flow
N/A
Price / Book
N/A

Miscellaneous

Free Float
N/A
Market Cap
$1.34 billion
Optionable
N/A
Beta
N/A
Elon Musk's Next Move Cover

Wondering when you'll finally be able to invest in SpaceX, Starlink, or X.AI? Enter your email address to learn when Elon Musk will let these companies finally IPO.

Get This Free Report

This page (NYSE:GRDN) was last updated on 4/2/2025 by MarketBeat.com Staff
From Our Partners